Clinical practice guidelines for breast cancer rehabilitation: Syntheses of guideline recommendations and qualitative appraisals

Susan R. Harris, Kathryn H. Schmitz, Kristin L. Campbell, Margaret L. McNeely

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

BACKGROUND: Despite strides in early detection and management of breast cancer, the primary treatments for this disease continue to result in physical impairments for some of the nearly 3 million people diagnosed annually. Over the past decade, evidence-based clinical practice guidelines (CPGs) have been developed with goals of preventing and ameliorating these impairments. However, translation of these guidelines into clinical practice needs to be accelerated. METHODS: Relevant health science databases (2001- 2011) were searched to identify CPGs on breast cancer rehabilitation for the following impairments: upper extremity restrictions, lymphedema, pain, fatigue, chemotherapy-induced peripheral neuropathy, treatment-related cardiotoxicity, bone health, and weight management. RESULTS: Recommendations from 19 relevant CPGs were first summarized by impairment within tables; commonalities across guidelines, within each impairment, were then synthesized within the article. The CPGs were rated using the Appraisal of Guidelines for Research and Evaluation II (AGREE II); wide variability was noted in rigor of development, clarity of presentation, and stakeholder involvement. The most rigorous and comprehensive of those rated was the adult cancer pain guideline from the Scottish Intercollegiate Guidelines Network. CONCLUSIONS: Based on a large body of evidence published in recent years, including randomized trials and systematic reviews, there is an urgent need for updating the guidelines on upper extremity musculoskeletal impairments and lymphedema. Furthermore, additional research is needed to provide an evidence base for developing rehabilitation guidelines on management of other impairments identified in the prospective surveillance model, eg, arthralgia.

Original languageEnglish (US)
Pages (from-to)2312-2324
Number of pages13
JournalCancer
Volume118
Issue numberSUPPL.8
DOIs
StatePublished - Apr 15 2012

Fingerprint

Practice Guidelines
Rehabilitation
Guidelines
Breast Neoplasms
Lymphedema
Upper Extremity
Evidence-Based Practice
Health
Arthralgia
Peripheral Nervous System Diseases
Fatigue
Databases
Weights and Measures
Bone and Bones
Drug Therapy
Pain
Therapeutics
Research

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Harris, Susan R. ; Schmitz, Kathryn H. ; Campbell, Kristin L. ; McNeely, Margaret L. / Clinical practice guidelines for breast cancer rehabilitation : Syntheses of guideline recommendations and qualitative appraisals. In: Cancer. 2012 ; Vol. 118, No. SUPPL.8. pp. 2312-2324.
@article{22cb031a6c5846ee8bbb57a663733426,
title = "Clinical practice guidelines for breast cancer rehabilitation: Syntheses of guideline recommendations and qualitative appraisals",
abstract = "BACKGROUND: Despite strides in early detection and management of breast cancer, the primary treatments for this disease continue to result in physical impairments for some of the nearly 3 million people diagnosed annually. Over the past decade, evidence-based clinical practice guidelines (CPGs) have been developed with goals of preventing and ameliorating these impairments. However, translation of these guidelines into clinical practice needs to be accelerated. METHODS: Relevant health science databases (2001- 2011) were searched to identify CPGs on breast cancer rehabilitation for the following impairments: upper extremity restrictions, lymphedema, pain, fatigue, chemotherapy-induced peripheral neuropathy, treatment-related cardiotoxicity, bone health, and weight management. RESULTS: Recommendations from 19 relevant CPGs were first summarized by impairment within tables; commonalities across guidelines, within each impairment, were then synthesized within the article. The CPGs were rated using the Appraisal of Guidelines for Research and Evaluation II (AGREE II); wide variability was noted in rigor of development, clarity of presentation, and stakeholder involvement. The most rigorous and comprehensive of those rated was the adult cancer pain guideline from the Scottish Intercollegiate Guidelines Network. CONCLUSIONS: Based on a large body of evidence published in recent years, including randomized trials and systematic reviews, there is an urgent need for updating the guidelines on upper extremity musculoskeletal impairments and lymphedema. Furthermore, additional research is needed to provide an evidence base for developing rehabilitation guidelines on management of other impairments identified in the prospective surveillance model, eg, arthralgia.",
author = "Harris, {Susan R.} and Schmitz, {Kathryn H.} and Campbell, {Kristin L.} and McNeely, {Margaret L.}",
year = "2012",
month = "4",
day = "15",
doi = "10.1002/cncr.27461",
language = "English (US)",
volume = "118",
pages = "2312--2324",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "SUPPL.8",

}

Clinical practice guidelines for breast cancer rehabilitation : Syntheses of guideline recommendations and qualitative appraisals. / Harris, Susan R.; Schmitz, Kathryn H.; Campbell, Kristin L.; McNeely, Margaret L.

In: Cancer, Vol. 118, No. SUPPL.8, 15.04.2012, p. 2312-2324.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical practice guidelines for breast cancer rehabilitation

T2 - Syntheses of guideline recommendations and qualitative appraisals

AU - Harris, Susan R.

AU - Schmitz, Kathryn H.

AU - Campbell, Kristin L.

AU - McNeely, Margaret L.

PY - 2012/4/15

Y1 - 2012/4/15

N2 - BACKGROUND: Despite strides in early detection and management of breast cancer, the primary treatments for this disease continue to result in physical impairments for some of the nearly 3 million people diagnosed annually. Over the past decade, evidence-based clinical practice guidelines (CPGs) have been developed with goals of preventing and ameliorating these impairments. However, translation of these guidelines into clinical practice needs to be accelerated. METHODS: Relevant health science databases (2001- 2011) were searched to identify CPGs on breast cancer rehabilitation for the following impairments: upper extremity restrictions, lymphedema, pain, fatigue, chemotherapy-induced peripheral neuropathy, treatment-related cardiotoxicity, bone health, and weight management. RESULTS: Recommendations from 19 relevant CPGs were first summarized by impairment within tables; commonalities across guidelines, within each impairment, were then synthesized within the article. The CPGs were rated using the Appraisal of Guidelines for Research and Evaluation II (AGREE II); wide variability was noted in rigor of development, clarity of presentation, and stakeholder involvement. The most rigorous and comprehensive of those rated was the adult cancer pain guideline from the Scottish Intercollegiate Guidelines Network. CONCLUSIONS: Based on a large body of evidence published in recent years, including randomized trials and systematic reviews, there is an urgent need for updating the guidelines on upper extremity musculoskeletal impairments and lymphedema. Furthermore, additional research is needed to provide an evidence base for developing rehabilitation guidelines on management of other impairments identified in the prospective surveillance model, eg, arthralgia.

AB - BACKGROUND: Despite strides in early detection and management of breast cancer, the primary treatments for this disease continue to result in physical impairments for some of the nearly 3 million people diagnosed annually. Over the past decade, evidence-based clinical practice guidelines (CPGs) have been developed with goals of preventing and ameliorating these impairments. However, translation of these guidelines into clinical practice needs to be accelerated. METHODS: Relevant health science databases (2001- 2011) were searched to identify CPGs on breast cancer rehabilitation for the following impairments: upper extremity restrictions, lymphedema, pain, fatigue, chemotherapy-induced peripheral neuropathy, treatment-related cardiotoxicity, bone health, and weight management. RESULTS: Recommendations from 19 relevant CPGs were first summarized by impairment within tables; commonalities across guidelines, within each impairment, were then synthesized within the article. The CPGs were rated using the Appraisal of Guidelines for Research and Evaluation II (AGREE II); wide variability was noted in rigor of development, clarity of presentation, and stakeholder involvement. The most rigorous and comprehensive of those rated was the adult cancer pain guideline from the Scottish Intercollegiate Guidelines Network. CONCLUSIONS: Based on a large body of evidence published in recent years, including randomized trials and systematic reviews, there is an urgent need for updating the guidelines on upper extremity musculoskeletal impairments and lymphedema. Furthermore, additional research is needed to provide an evidence base for developing rehabilitation guidelines on management of other impairments identified in the prospective surveillance model, eg, arthralgia.

UR - http://www.scopus.com/inward/record.url?scp=84859639034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859639034&partnerID=8YFLogxK

U2 - 10.1002/cncr.27461

DO - 10.1002/cncr.27461

M3 - Article

C2 - 22488705

AN - SCOPUS:84859639034

VL - 118

SP - 2312

EP - 2324

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - SUPPL.8

ER -